The display screens of modern televisions, cell phones and computer monitors rely on liquid crystals—materials that flow like liquids but have molecules oriented in crystal-like structures. However, liquid crystals may have played a far more ancient role: helping to assemble Earth’s first biomolecules. Researchers reporting in ACS Nano have found that short RNA molecules can form liquid crystals that encourage growth into longer chains.

Scientists have speculated that life on Earth originated in an “RNA world,” where RNA fulfilled the dual role of carrying genetic information and conducting metabolism before the dawn of DNA or proteins. Indeed, researchers have discovered catalytic RNA strands, or “ribozymes,” in modern genomes. Known ribozymes are about 16–150 nucleotides in length, so how did these sequences assemble in a primordial world without existing ribozymes or proteins? Tommaso Bellini and colleagues wondered if liquid crystals could help guide short RNA precursors to form longer strands.

To find out, the researchers explored different scenarios under which short RNAs could self-assemble. They found that at high concentrations, short RNA sequences (either 6 or 12 nucleotides long) spontaneously ordered into liquid crystal phases. Liquid crystals formed even more readily when the researchers added magnesium ions, which stabilized the crystals, or polyethylene glycol, which sequestered RNA into highly concentrated microdomains. Once the RNAs were held together in liquid crystals, a chemical activator could efficiently join their ends into much longer strands. This arrangement also helped avoid the formation of circular RNAs that could not be lengthened further. The researchers point out that polyethylene glycol and the chemical activator would not be found under primordial conditions, but they say that other molecular species could have played similar, if less efficient, roles.

Now in its 12th year, the Cell & Gene Meeting on the Mesa continues to grow, much like the stem cells that are the center of its business and scientific discussions.

The field of epigenetics sits precariously on the precipice of the classic nature versus nurture debate. Instead of a simple environment versus genetics dichotomy, epigenetic examines how specific genes are either switched on or off through external forces encountered in a person’s lifetime. Striking new research from scientists at the University of British Columbia and Harvard University is suggesting that adults who were victims of abuse as children may carry an imprint of that trauma in regions of their DNA.

Today, we would like to share with you a talk by Dr. Michael West from AgeX Therapeutics, a company developing therapies to combat age-related diseases by encouraging the body to regenerate cells and tissues.

On July 12th, we hosted our first conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, at the Frederick P. Rose Auditorium, which is part of the Cooper Union campus in New York City. The packed event saw a range of people from research, investment, and the wider community coming together for a day of science and biotech business presentations and panels.

Continue reading “The Reversibility of Human Aging” »

Cancer is tough to treat because it’s essentially the body’s own cells gone rogue. This year’s laureates found a way to tweak the immune system to attack cancer cells.

To rapidly detect the presence of E. coli in drinking water, Cornell University food scientists now can employ a bacteriophage — a genetically engineered virus — in a test used in hard-to-reach areas around the world.

My Journey With Cancer and the Hope for the Future

I would like to share a story. A story about sadness, depression, anger, and frustration. But most of all this is my personal story about triumphing over the death sentence of #cancer. I hope this story will give others who went through and are going through hope for the future.

My story started about 5 years ago on a cold winter day. Up until this point my life seemed invincible. That all changed. At the time I was working at the plasma center and we were preparing for an audit by the FDA. Before an audit we would have the floors waxed and make the center look as nice as possible. A few co-workers and I stayed late to help move the donor beds. I knew I had been feeling pain in my neck/shoulder area for a few weeks so I really didn’t want to. I figured it must have been from repetitive motions at work. I decided to just ignore it and help anyways: this decision changed my life dramatically.

Continue reading “My Journey With Cancer and Hope for the Future!” »

Promising early results are in from a phase 1 clinical trial into the safety and efficacy of a new cancer vaccine. The new treatment is designed to stimulate the immune system into attacking certain cancers known to overexpress a specific protein.

Liz talking about gene therapy.

Liz Parrish in conversation with Nick Delgado, PhD, ABAAHP, CHT, Lifestyle Anti-Aging Medicine Author.

Continue reading “Liz Parrish in an insightful conversation with Nick Delgado (Sept 22, 2018 @RAADfest)” »